Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Tax Withholding |
2025-03-03 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
17,862 | $0.67 | 132,068 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-03 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
46,430 | $0 | 132,068 (Direct) |
View |
| 2025-02-13 Option Award |
2025-02-18 4:22 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
371,080 | $0 | 371,080 (Direct) |
View |
| 2024-02-28 Tax Withholding |
2024-02-29 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
11,793 | $2.62 | 90,270 (Direct) |
View |
| 2024-02-28 Exercise |
2024-02-29 4:33 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
29,243 | $0 | 90,270 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 4:19 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
119,320 | $0 | 119,320 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-01 4:56 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
5,330 | $2.17 | 54,283 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-01 4:56 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
18,717 | $0 | 54,283 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 5:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
119,450 | $0 | 119,450 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:18 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
3,337 | $2.85 | 27,763 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:18 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
11,300 | $0 | 27,763 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:02 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
79,630 | $0 | 79,630 (Direct) |
View |
Ownership |
2021-09-27 4:06 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting |
0 | $0 | 58,884 (Direct) |
View |